Jong-Hyun Cho

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
There are currently six nucleoside reverse transcriptase inhibitors (NRTI) that are FDA approved for human clinical use and these remain the backbone of current HIV therapy. In order for these NRTIs to be effective they need to be phosphorylated consecutively by cellular kinases to their triphosphate forms. Herein, we report the synthesis of C-6 modified(More)
  • 1